0

531541

KOBO

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

KOBO BIOTECH LIMITED Share Price Today

Investment Returns

Over 1 Month 93.41% Over 3 Months 114.16% Over 6 Months 123.76% Over 1 Year 91.92%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

KOBO BIOTECH LIMITED fundamentals


  • Market cap (Cr) [-]
  • P/E Ratio (TTM) [-]
  • Beta [-]
  • Book Value / share [-]
  • Return on equity [-]%
  • EPS (TTM) [-]
  • Dividend yield [-]%
  • Net profit/quarter (Cr) [-]
info icon alternate text
  • Market cap (Cr) 12.50
  • P/E Ratio (TTM) -2.36
  • Beta 0.34
  • Book Value / share -55.78
  • Return on equity 0.00%
  • EPS (TTM) 0.00
  • Dividend yield [-]%
  • Net profit/quarter (Cr) -1.33
info icon alternate text

KOBO BIOTECH LIMITED Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition
info-icon
Revenue
Net income
Particulars JUN 2024 (Values in Cr)
Revenue 0.00
Operating Expense 1.35
Net Profit -1.33
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.56
EBITDA -0.32
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 1.26
Net Profit -1.26
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.53
EBITDA -0.25
Effective Tax Rate (%) 0.00
Particulars DEC 2023 (Values in Cr)
Revenue 0.00
Operating Expense 1.23
Net Profit -1.23
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.52
EBITDA -0.19
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 0.00
Operating Expense 1.22
Net Profit -1.22
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.51
EBITDA -0.19
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 0.00
Operating Expense 1.24
Net Profit -1.23
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -0.51
EBITDA -0.21
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 0.00
Operating Expense 4.94
Net Profit -4.93
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -2.07
EBITDA -0.85
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 0.00
Operating Expense 5.57
Net Profit -5.55
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -2.33
EBITDA -1.47
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 15.24
Net Profit -15.23
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -6.39
EBITDA -10.48
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.00
Operating Expense 19.27
Net Profit -19.23
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -8.07
EBITDA -2.75
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 0.00
Operating Expense 21.04
Net Profit -21.01
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -8.82
EBITDA -0.66
Effective Tax Rate (%) 0.00
Particulars MAR 2015 (Values in Cr)
Book Value / Share 23.59
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 3.38
EBITDA Margin -0.64
Particulars MAR 2014 (Values in Cr)
Book Value / Share 23.59
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.56
EBITDA Margin -0.64
Particulars MAR 2013 (Values in Cr)
Book Value / Share 39.06
ROE % 16.72
ROCE % 12.63
Total Debt to Total Equity 1.83
EBITDA Margin 10.45
Particulars MAR 2012 (Values in Cr)
Book Value / Share 32.84
ROE % 22.13
ROCE % 17.30
Total Debt to Total Equity 1.82
EBITDA Margin 16.66
Particulars MAR 2011 (Values in Cr)
Book Value / Share 27.29
ROE % 14.91
ROCE % 10.76
Total Debt to Total Equity 2.14
EBITDA Margin 17.19
Particulars MAR 2023 (Values in Cr)
Book Value / Share -53.72
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2022 (Values in Cr)
Book Value / Share -51.39
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share -45.00
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2020 (Values in Cr)
Book Value / Share -36.92
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2019 (Values in Cr)
Book Value / Share -28.11
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2015 (Values in Cr)
Cash & Short Term Investments 5.64
Total Assets 395.57
Total Liabilities 395.57
Total Equity 53.07
Share Outstanding 2
Price to Book Ratio 4.42
Return on Assets (%) -8.80
Return on Capital (%) -15.51
Particulars MAR 2014 (Values in Cr)
Cash & Short Term Investments 16.47
Total Assets 411.67
Total Liabilities 411.67
Total Equity 87.89
Share Outstanding 2
Price to Book Ratio 0.44
Return on Assets (%) 3.39
Return on Capital (%) 5.73
Particulars MAR 2013 (Values in Cr)
Cash & Short Term Investments 16.47
Total Assets 411.67
Total Liabilities 411.67
Total Equity 87.89
Share Outstanding 2
Price to Book Ratio 0.41
Return on Assets (%) 3.39
Return on Capital (%) 5.73
Particulars MAR 2012 (Values in Cr)
Cash & Short Term Investments 25.13
Total Assets 345.60
Total Liabilities 345.60
Total Equity 75.65
Share Outstanding 2
Price to Book Ratio 1.00
Return on Assets (%) 4.37
Return on Capital (%) 8.65
Particulars MAR 2011 (Values in Cr)
Cash & Short Term Investments 2.49
Total Assets 249.98
Total Liabilities 249.98
Total Equity 61.40
Share Outstanding 2
Price to Book Ratio 1.26
Return on Assets (%) 3.93
Return on Capital (%) 5.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 75.33
Total Liabilities 75.33
Total Equity -127.98
Share Outstanding 2
Price to Book Ratio -0.04
Return on Assets (%) -7.37
Return on Capital (%) -46.83
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 79.18
Total Liabilities 79.18
Total Equity -122.42
Share Outstanding 2
Price to Book Ratio -0.11
Return on Assets (%) -19.22
Return on Capital (%) -83.26
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.55
Total Assets 230.58
Total Liabilities 230.58
Total Equity -107.20
Share Outstanding 2
Price to Book Ratio -0.16
Return on Assets (%) -8.34
Return on Capital (%) -12.54
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 236.33
Total Liabilities 236.33
Total Equity -87.97
Share Outstanding 2
Price to Book Ratio -0.08
Return on Assets (%) -8.88
Return on Capital (%) -18.94
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 239.44
Total Liabilities 239.44
Total Equity -66.96
Share Outstanding 2
Price to Book Ratio -0.16
Return on Assets (%) -10.21
Return on Capital (%) -20.82
Particulars MAR 2015 (Values in Cr)
Net Income -34.27
Cash from Operations 7.26
Cash from Investing -4.70
Cash from Financing -12.84
Net change in Cash -10.83
Free Cash Flow 11.96
Particulars MAR 2014 (Values in Cr)
Net Income 14.87
Cash from Operations 38.50
Cash from Investing -6.99
Cash from Financing -38.38
Net change in Cash -8.65
Free Cash Flow 46.35
Particulars MAR 2013 (Values in Cr)
Net Income 14.87
Cash from Operations 38.50
Cash from Investing -6.99
Cash from Financing -38.38
Net change in Cash -8.65
Free Cash Flow 46.35
Particulars MAR 2012 (Values in Cr)
Net Income 17.67
Cash from Operations 65.88
Cash from Investing -14.43
Cash from Financing -26.81
Net change in Cash 22.63
Free Cash Flow 80.34
Particulars MAR 2023 (Values in Cr)
Net Income -5.55
Cash from Operations 0.87
Cash from Investing 0.00
Cash from Financing -0.87
Net change in Cash 0.00
Free Cash Flow 0.87
Particulars MAR 2022 (Values in Cr)
Net Income -15.22
Cash from Operations 93.75
Cash from Investing 25.09
Cash from Financing -120.28
Net change in Cash -1.43
Free Cash Flow 93.75
Particulars MAR 2021 (Values in Cr)
Net Income -19.23
Cash from Operations 2.50
Cash from Investing 0.00
Cash from Financing -1.07
Net change in Cash 1.43
Free Cash Flow 2.50
Particulars MAR 2020 (Values in Cr)
Net Income -21.00
Cash from Operations 14.47
Cash from Investing 0.00
Cash from Financing -14.47
Net change in Cash 0.00
Free Cash Flow 14.47
Particulars MAR 2019 (Values in Cr)
Net Income -24.45
Cash from Operations 20.94
Cash from Investing 0.00
Cash from Financing -20.94
Net change in Cash 0.00
Free Cash Flow 20.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.47 14.24 1.66 264.15 23.12 38.85
BLISS GVS PHARMA LTD 438.05 35.44 3.88 4634.09 118.35 462.70
CIPLA LTD. 1400.70 29.73 3.28 113154.89 1165.55 1672.20
FERMENTA BIOTECH LIMITED 336.90 14.86 2.43 991.53 256.40 399.00
GLAXOSMITHKLINE PHARMACEUTICAL 2166.30 35.95 16.18 36698.43 2155.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 34.47 24.10 4.44 264.15 23.12 38.85
AMRUTANJAN HEALTH CARE LTD. 551.70 24.73 4.30 1595.00 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8598.60 112.30 24.62 21496.50 7630.00 10653.05
BLISS GVS PHARMA LTD 438.05 47.10 4.01 4634.09 118.35 462.70

KOBO BIOTECH LIMITED shareholding pattern

Holding
55.05%
44.94%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

KOBO BIOTECH LIMITED Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
5.23 4.80 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 4.60
  • 26 Days 3.50
  • 10 Days 4.20
  • 50 Days 3.10
  • 12 Days 4.00
  • 100 Days 2.80
  • 20 Days 3.70
  • 200 Days 2.80
4.99 PIVOT
First Support 4.99 First Resistance 4.99 Second Support 4.99 Second Resistance 4.99 Third Support 4.99 Third Resistance 4.99
RSI 89.16 ADX 66.34 MACD 0.56 Williams % R 0.00 Commodity Channel Index (CCI) 159.25
Date 2026-06-05 Week 19976.00 Same Day 15365.00 Month 16729.00
1 Year 0.34 3 Year 0.38
Over 1 Month
93.41% down
Over 1 Year
91.92% down
Over 3 Months
114.16% down
Over 3 Years
25.24% down
Over 6 Months
123.76% down
Over 5 Years
-2.96% down

KOBO BIOTECH LIMITED Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
21 Sep 2012 1.0 Final 25 Sep 2012 Equity shares
22 Jul 2011 1.0 Final 26 Jul 2011 Equity shares
23 Sep 2010 1.0 Final 25 Sep 2010 Equity shares

Top Gainers

Top Losers

stock
Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Kobo Biotech Ltd?

Answer Field

Kobo Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 5.23 as on Jun 08 2026 03:10 PM.

What is the Market Cap of Kobo Biotech Ltd Share?

Answer Field

The market cap of Kobo Biotech Ltd for NSE ₹ 0.00 & for BSE ₹ 12.50 as on Jun 08 2026 03:10 PM.

What is the 52 Week High and Low of Kobo Biotech Ltd?

Answer Field

The 52 Week High and Low of Kobo Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 5.23 and ₹ 1.99.

What is 1 year return for Kobo Biotech Ltd?

Answer Field

The 1 year returns on the stock has been 91.92%.

What is the P/E Ratio of Kobo Biotech Ltd Share?

Answer Field

As on Jun 08 2026 03:10 PM the price-to-earnings (PE) ratio for Kobo Biotech Ltd share is -2.36.

What is the PB ratio of Kobo Biotech Ltd Share?

Answer Field

As on Jun 08 2026 03:10 PM, the price-to-book (PB) ratio for Kobo Biotech Ltd share is -55.78.

How to Buy Kobo Biotech Ltd Share?

Answer Field

You can trade in Kobo Biotech Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Kobo Biotech Ltd Share on Bajaj Broking App?

Answer Field

To buy Kobo Biotech Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Kobo Biotech Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|